This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Enanta Pharmaceuticals, Inc.
Drug Names(s): EP024297, EP 024297
Description: EP-024297 is a Farnesoid X receptor (FXR) agonist compound being developed by Enanta.
Additional information available to subscribers only: